Find out more about GSK’s therapeutic areas
Almost half the vaccines and medicines in our pipeline address infectious diseases.
Our work in HIV is through ViiV, the world’s only specialist HIV pharmaceutical company.
We develop transformational cancer medicines with life-changing potential for patients.
We’re focused on unlocking the science of the immune system.
We also pursue other opportunity-driven therapies where the science aligns with our strategy.
Behind the Science is an online magazine featuring news, articles, Q&A, and the latest research findings behind the science of GSK’s therapeutic areas.